AbbVie
ABBV
#30
Rank
A$454.54 B
Marketcap
$257.22
Share price
-0.13%
Change (1 day)
22.07%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of September 2024 : A$109.12 Billion

According to AbbVie's latest financial reports the company's total debt is A$109.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$87.16 B-6.25%
2022-12-31A$92.97 B-12.1%
2021-12-31A$105.77 B-5.49%
2020-12-31A$111.91 B17.43%
2019-12-31A$95.30 B66.56%
2018-12-31A$57.22 B19.55%
2017-12-31A$47.86 B-6.35%
2016-12-31A$51.11 B17.56%
2015-12-31A$43.47 B137.56%
2014-12-31A$18.30 B10.87%
2013-12-31A$16.50 B9.45%
2012-12-31A$15.08 B32114.79%
2011-12-31A$46.81 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$102.27 B-6.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$78.90 B-27.69%๐Ÿ‡บ๐Ÿ‡ธ USA
A$47.77 B-56.22%๐Ÿ‡บ๐Ÿ‡ธ USA
A$92.72 B-15.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$35.84 B-67.15%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.21 B-90.64%๐Ÿ‡บ๐Ÿ‡ธ USA
A$32.99 B-69.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$51.47 B-52.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$0.38 B-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA